title: Utility of cardiac MRI for diagnosis and post-treatment follow-up of lupus myocarditis.
abstract: Clinical myocardial involvement in systemic lupus erythematosus is rare. Lupus myocarditis is usually not detected until significant decrease in myocardial function becomes clinically evident. This case report describes MR imaging of lupus myocarditis that was used for diagnosis and follow up in a patient who declined cardiac biopsy. We also review the literature related to myocardial imaging by MRI.
authors.affiliation: Departments of Radiological Sciences and Cardiology, University of California, Irvine, CA, USA.
authors.forename: Farhood
authors.initials: F
authors.lastname: Saremi
authors.forename: Oganes
authors.initials: O
authors.lastname: Ashikyan
authors.forename: Rajeev
authors.initials: R
authors.lastname: Saggar
authors.forename: John
authors.initials: J
authors.lastname: Vu
authors.forename: Molly E
authors.initials: ME
authors.lastname: Nunez
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D018501:Antirheumatic Agents; D005938:Glucocorticoids; D003520:Cyclophosphamide; D011241:Prednisone